A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04092686 |
|
Recruitment Status :
Completed
First Posted : September 17, 2019
Last Update Posted : November 21, 2023
|
Sponsor:
Sumitomo Pharma America, Inc.
Information provided by (Responsible Party):
Sumitomo Pharma America, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | June 14, 2023 |
| Actual Study Completion Date : | June 14, 2023 |